Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q15410175> ?p ?o }
Showing triples 1 to 42 of
42
with 100 triples per page.
- Q15410175 subject Q16819643.
- Q15410175 subject Q8492996.
- Q15410175 subject Q8791920.
- Q15410175 abstract "Tofogliflozin (USAN, codenamed CSG452) is an experimental drug for the treatment of diabetes mellitus and is being developed by Chugai Pharma in collaboration with Kowa and Sanofi. It is an inhibitor of subtype 2 sodium-glucose transport protein (SGLT2), which is responsible for at least 90% of the glucose reabsorption in the kidney. As of Template:MONTHNAME 2012[[Category:Articles containing potentially dated statements from Template:MONTHNAME 2012]], the drug is in Phase III clinical trials.".
- Q15410175 atcPrefix "None".
- Q15410175 casNumber "1201913-82-7".
- Q15410175 casSupplemental "(anhydrous)".
- Q15410175 iupacName "(1S,3R,4S,5S,6R)-6-(4-Ethylbenzyl)-6'-(hydroxymethyl)-3',4',5',6'-tetrahydro-3H-spiro[2-benzofuran-1,2'-pyran]-3',4',5'-triol hydrate (1:1)".
- Q15410175 pubchem "46908928".
- Q15410175 thumbnail Tofogliflozin_monohydrate_skeletal_3D.svg?width=300.
- Q15410175 wikiPageExternalLink Chemical-Structure.28530778.html.
- Q15410175 wikiPageExternalLink CHEMBL2110731.
- Q15410175 wikiPageWikiLink Q12206.
- Q15410175 wikiPageWikiLink Q15318183.
- Q15410175 wikiPageWikiLink Q158205.
- Q15410175 wikiPageWikiLink Q16819643.
- Q15410175 wikiPageWikiLink Q182854.
- Q15410175 wikiPageWikiLink Q2311683.
- Q15410175 wikiPageWikiLink Q2745207.
- Q15410175 wikiPageWikiLink Q3041588.
- Q15410175 wikiPageWikiLink Q30612.
- Q15410175 wikiPageWikiLink Q4391435.
- Q15410175 wikiPageWikiLink Q462174.
- Q15410175 wikiPageWikiLink Q4926095.
- Q15410175 wikiPageWikiLink Q6120337.
- Q15410175 wikiPageWikiLink Q750619.
- Q15410175 wikiPageWikiLink Q8492996.
- Q15410175 wikiPageWikiLink Q8791920.
- Q15410175 atcPrefix "None".
- Q15410175 casNumber "1201913".
- Q15410175 drugName "Tofogliflozin monohydrate".
- Q15410175 iupacName "240.0".
- Q15410175 pubchem "46908928".
- Q15410175 type ChemicalSubstance.
- Q15410175 type Drug.
- Q15410175 type ChemicalObject.
- Q15410175 type Thing.
- Q15410175 type Q8386.
- Q15410175 comment "Tofogliflozin (USAN, codenamed CSG452) is an experimental drug for the treatment of diabetes mellitus and is being developed by Chugai Pharma in collaboration with Kowa and Sanofi. It is an inhibitor of subtype 2 sodium-glucose transport protein (SGLT2), which is responsible for at least 90% of the glucose reabsorption in the kidney. As of Template:MONTHNAME 2012[[Category:Articles containing potentially dated statements from Template:MONTHNAME 2012]], the drug is in Phase III clinical trials.".
- Q15410175 label "Tofogliflozin".
- Q15410175 depiction Tofogliflozin_monohydrate_skeletal_3D.svg.
- Q15410175 name "Tofogliflozin monohydrate".